Eintrag weiter verarbeiten
Beta-trace protein as a new non-invasive immunological marker for quinolinic acid-induced impaired blood-brain barrier integrity
Gespeichert in:
Veröffentlicht in: | Scientific reports 7(2017) Artikel-Nummer 43642, 8 Seiten |
---|---|
Personen und Körperschaften: | , |
Titel: | Beta-trace protein as a new non-invasive immunological marker for quinolinic acid-induced impaired blood-brain barrier integrity/ Andreas Baranyi, Omid Amouzadeh-Ghadikolai, Dirk von Lewinski, Robert J. Breitenecker, Tatjana Stojakovic, Winfried März, Christoph Robier, Hans-Bernd Rothenhäusler, Harald Mangge & Andreas Meinitzer |
Format: | E-Book-Kapitel |
Sprache: | Englisch |
veröffentlicht: |
09 March 2017
|
Gesamtaufnahme: |
: Scientific reports, 7(2017) Artikel-Nummer 43642, 8 Seiten
, volume:7 |
Quelle: | Verbunddaten SWB Lizenzfreie Online-Ressourcen |
LEADER | 03737caa a2200529 4500 | ||
---|---|---|---|
001 | 0-1581124600 | ||
003 | DE-627 | ||
005 | 20220815013846.0 | ||
007 | cr uuu---uuuuu | ||
008 | 180919s2017 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1038/srep43642 |2 doi | |
035 | |a (DE-627)1581124600 | ||
035 | |a (DE-576)511124600 | ||
035 | |a (DE-599)BSZ511124600 | ||
035 | |a (OCoLC)1341018840 | ||
040 | |a DE-627 |b ger |c DE-627 |e rda | ||
041 | |a eng | ||
100 | 1 | |a Baranyi, Andreas |e VerfasserIn |0 (DE-588)116736449X |0 (DE-627)1031032460 |0 (DE-576)511124716 |4 aut | |
245 | 1 | 0 | |a Beta-trace protein as a new non-invasive immunological marker for quinolinic acid-induced impaired blood-brain barrier integrity |c Andreas Baranyi, Omid Amouzadeh-Ghadikolai, Dirk von Lewinski, Robert J. Breitenecker, Tatjana Stojakovic, Winfried März, Christoph Robier, Hans-Bernd Rothenhäusler, Harald Mangge & Andreas Meinitzer |
264 | 1 | |c 09 March 2017 | |
300 | |a 8 | ||
336 | |a Text |b txt |2 rdacontent | ||
337 | |a Computermedien |b c |2 rdamedia | ||
338 | |a Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Gesehen am 19.08.2018 | ||
520 | |a Quinolinic acid, a macrophage/microglia-derived excitotoxin fulfills a plethora of functions such as neurotoxin, gliotoxin, and proinflammatory mediator, and it alters the integrity and cohesion of the blood-brain barrier in several pathophysiological states. Beta-trace protein (BTP), a monomeric glycoprotein, is known to indicate cerebrospinal fluid leakage. Thus, the prior aim of this study was to investigate whether BTP might non-invasively indicate quinolinic acid-induced impaired blood-brain barrier integrity. The research hypotheses were tested in three subsamples with different states of immune activation (patients with HCV-infection and interferon-α, patients with major depression, and healthy controls). BTP has also been described as a sensitive marker in detecting impaired renal function. Thus, the renal function has been considered. Our study results revealed highest quinolinic acid and highest BTP- levels in the subsample of patients with HCV in comparison with the other subsamples with lower or no immune activation (quinolinic acid: F = 21.027, p < 0.001 [ANOVA]; BTP: F = 6.792, p < 0.01 [ANOVA]). In addition, a two-step hierarchical linear regression model showed that significant predictors of BTP levels are quinolinic acid, glomerular filtration rate and age. The neurotoxin quinolinic acid may impair blood-brain barrier integrity. BTP might be a new non-invasive biomarker to indicate quinolinic acid-induced impaired blood-brain barrier integrity. | ||
700 | 1 | |a März, Winfried |d 1958- |e VerfasserIn |0 (DE-588)1027603599 |0 (DE-627)729463605 |0 (DE-576)373454635 |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Scientific reports |d [London] : Macmillan Publishers Limited, part of Springer Nature, 2011 |g 7(2017) Artikel-Nummer 43642, 8 Seiten |h Online-Ressource |w (DE-627)663366712 |w (DE-600)2615211-3 |w (DE-576)346641179 |x 2045-2322 |7 nnns |
773 | 1 | 8 | |g volume:7 |g year:2017 |g extent:8 |
856 | 4 | 0 | |u http://dx.doi.org/10.1038/srep43642 |x Verlag |x Resolving-System |z kostenfrei |3 Volltext |
856 | 4 | 0 | |u https://www.nature.com/articles/srep43642 |x Verlag |z kostenfrei |3 Volltext |
936 | u | w | |d 7 |j 2017 |g 8 |y 7(2017) Artikel-Nummer 43642, 8 Seiten |
951 | |a AR | ||
856 | 4 | 0 | |u http://dx.doi.org/10.1038/srep43642 |9 LFER |
852 | |a LFER |z 2018-10-10T00:00:00Z | ||
970 | |c OD | ||
971 | |c EBOOK | ||
972 | |c EBOOK | ||
973 | |c Aufsatz | ||
935 | |a lfer | ||
900 | |a Marz, Winfried | ||
900 | |a März, W. | ||
900 | |a März, Winifred | ||
900 | |a März, Winfried Georg | ||
900 | |a März, Winfried G. | ||
951 | |b XA-AT | ||
980 | |a 1581124600 |b 0 |k 1581124600 |o 511124600 |c lfer |
openURL |
url_ver=Z39.88-2004&ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fvufind.svn.sourceforge.net%3Agenerator&rft.title=Beta-trace+protein+as+a+new+non-invasive+immunological+marker+for+quinolinic+acid-induced+impaired+blood-brain+barrier+integrity&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Adc&rft.creator=Baranyi%2C+Andreas&rft.pub=&rft.format=Journal&rft.language=English&rft.issn=2045-2322 |
---|
_version_ | 1757949970417188864 |
---|---|
access_facet | Electronic Resources |
author | Baranyi, Andreas, März, Winfried |
author_facet | Baranyi, Andreas, März, Winfried |
author_role | aut, aut |
author_sort | Baranyi, Andreas |
author_variant | a b ab, w m wm |
callnumber-sort | |
collection | lfer |
container_reference | 7(2017) Artikel-Nummer 43642, 8 Seiten |
container_title | Scientific reports |
contents | Quinolinic acid, a macrophage/microglia-derived excitotoxin fulfills a plethora of functions such as neurotoxin, gliotoxin, and proinflammatory mediator, and it alters the integrity and cohesion of the blood-brain barrier in several pathophysiological states. Beta-trace protein (BTP), a monomeric glycoprotein, is known to indicate cerebrospinal fluid leakage. Thus, the prior aim of this study was to investigate whether BTP might non-invasively indicate quinolinic acid-induced impaired blood-brain barrier integrity. The research hypotheses were tested in three subsamples with different states of immune activation (patients with HCV-infection and interferon-α, patients with major depression, and healthy controls). BTP has also been described as a sensitive marker in detecting impaired renal function. Thus, the renal function has been considered. Our study results revealed highest quinolinic acid and highest BTP- levels in the subsample of patients with HCV in comparison with the other subsamples with lower or no immune activation (quinolinic acid: F = 21.027, p < 0.001 [ANOVA]; BTP: F = 6.792, p < 0.01 [ANOVA]). In addition, a two-step hierarchical linear regression model showed that significant predictors of BTP levels are quinolinic acid, glomerular filtration rate and age. The neurotoxin quinolinic acid may impair blood-brain barrier integrity. BTP might be a new non-invasive biomarker to indicate quinolinic acid-induced impaired blood-brain barrier integrity. |
ctrlnum | (DE-627)1581124600, (DE-576)511124600, (DE-599)BSZ511124600, (OCoLC)1341018840 |
doi_str_mv | 10.1038/srep43642 |
facet_avail | Online, Free |
finc_class_facet | not assigned |
finc_id_str | 0021320280 |
footnote | Gesehen am 19.08.2018 |
format | ElectronicBookComponentPart |
format_access_txtF_mv | Article, E-Article |
format_de105 | Ebook |
format_de14 | Article, E-Article |
format_de15 | Article, E-Article |
format_del152 | Buch |
format_detail_txtF_mv | text-online-monograph-child |
format_dezi4 | e-Book |
format_finc | Article, E-Article |
format_legacy | ElectronicBookPart |
format_strict_txtF_mv | E-Article |
geogr_code | not assigned |
geogr_code_person | Austria |
hierarchy_parent_id | 0-663366712 |
hierarchy_parent_title | Scientific reports |
hierarchy_sequence | 7(2017) Artikel-Nummer 43642, 8 Seiten |
hierarchy_top_id | 0-663366712 |
hierarchy_top_title | Scientific reports |
id | 0-1581124600 |
illustrated | Not Illustrated |
imprint | 09 March 2017 |
imprint_str_mv | 09 March 2017 |
institution | DE-D117, DE-105, LFER, DE-Ch1, DE-15, DE-14, DE-Zwi2 |
is_hierarchy_id | 0-1581124600 |
is_hierarchy_title | Beta-trace protein as a new non-invasive immunological marker for quinolinic acid-induced impaired blood-brain barrier integrity |
isil_str_mv | LFER |
issn | 2045-2322 |
kxp_id_str | 1581124600 |
language | English |
last_indexed | 2023-02-16T01:42:15.919Z |
marc024a_ct_mv | 10.1038/srep43642 |
match_str | baranyi2017betatraceproteinasanewnoninvasiveimmunologicalmarkerforquinolinicacidinducedimpairedbloodbrainbarrierintegrity |
mega_collection | Verbunddaten SWB, Lizenzfreie Online-Ressourcen |
misc_de105 | EBOOK |
multipart_link | 346641179 |
multipart_part | (346641179)7(2017) Artikel-Nummer 43642, 8 Seiten |
names_id_str_mv | (DE-588)116736449X, (DE-627)1031032460, (DE-576)511124716, (DE-588)1027603599, (DE-627)729463605, (DE-576)373454635 |
oclc_num | 1341018840 |
physical | 8 |
publishDate | 09 March 2017 |
publishDateSort | 2017 |
publishPlace | |
publisher | |
record_format | marcfinc |
record_id | 511124600 |
recordtype | marcfinc |
rvk_facet | No subject assigned |
source_id | 0 |
spelling | Baranyi, Andreas VerfasserIn (DE-588)116736449X (DE-627)1031032460 (DE-576)511124716 aut, Beta-trace protein as a new non-invasive immunological marker for quinolinic acid-induced impaired blood-brain barrier integrity Andreas Baranyi, Omid Amouzadeh-Ghadikolai, Dirk von Lewinski, Robert J. Breitenecker, Tatjana Stojakovic, Winfried März, Christoph Robier, Hans-Bernd Rothenhäusler, Harald Mangge & Andreas Meinitzer, 09 March 2017, 8, Text txt rdacontent, Computermedien c rdamedia, Online-Ressource cr rdacarrier, Gesehen am 19.08.2018, Quinolinic acid, a macrophage/microglia-derived excitotoxin fulfills a plethora of functions such as neurotoxin, gliotoxin, and proinflammatory mediator, and it alters the integrity and cohesion of the blood-brain barrier in several pathophysiological states. Beta-trace protein (BTP), a monomeric glycoprotein, is known to indicate cerebrospinal fluid leakage. Thus, the prior aim of this study was to investigate whether BTP might non-invasively indicate quinolinic acid-induced impaired blood-brain barrier integrity. The research hypotheses were tested in three subsamples with different states of immune activation (patients with HCV-infection and interferon-α, patients with major depression, and healthy controls). BTP has also been described as a sensitive marker in detecting impaired renal function. Thus, the renal function has been considered. Our study results revealed highest quinolinic acid and highest BTP- levels in the subsample of patients with HCV in comparison with the other subsamples with lower or no immune activation (quinolinic acid: F = 21.027, p < 0.001 [ANOVA]; BTP: F = 6.792, p < 0.01 [ANOVA]). In addition, a two-step hierarchical linear regression model showed that significant predictors of BTP levels are quinolinic acid, glomerular filtration rate and age. The neurotoxin quinolinic acid may impair blood-brain barrier integrity. BTP might be a new non-invasive biomarker to indicate quinolinic acid-induced impaired blood-brain barrier integrity., März, Winfried 1958- VerfasserIn (DE-588)1027603599 (DE-627)729463605 (DE-576)373454635 aut, Enthalten in Scientific reports [London] : Macmillan Publishers Limited, part of Springer Nature, 2011 7(2017) Artikel-Nummer 43642, 8 Seiten Online-Ressource (DE-627)663366712 (DE-600)2615211-3 (DE-576)346641179 2045-2322 nnns, volume:7 year:2017 extent:8, http://dx.doi.org/10.1038/srep43642 Verlag Resolving-System kostenfrei Volltext, https://www.nature.com/articles/srep43642 Verlag kostenfrei Volltext, http://dx.doi.org/10.1038/srep43642 LFER, LFER 2018-10-10T00:00:00Z |
spellingShingle | Baranyi, Andreas, März, Winfried, Beta-trace protein as a new non-invasive immunological marker for quinolinic acid-induced impaired blood-brain barrier integrity, Quinolinic acid, a macrophage/microglia-derived excitotoxin fulfills a plethora of functions such as neurotoxin, gliotoxin, and proinflammatory mediator, and it alters the integrity and cohesion of the blood-brain barrier in several pathophysiological states. Beta-trace protein (BTP), a monomeric glycoprotein, is known to indicate cerebrospinal fluid leakage. Thus, the prior aim of this study was to investigate whether BTP might non-invasively indicate quinolinic acid-induced impaired blood-brain barrier integrity. The research hypotheses were tested in three subsamples with different states of immune activation (patients with HCV-infection and interferon-α, patients with major depression, and healthy controls). BTP has also been described as a sensitive marker in detecting impaired renal function. Thus, the renal function has been considered. Our study results revealed highest quinolinic acid and highest BTP- levels in the subsample of patients with HCV in comparison with the other subsamples with lower or no immune activation (quinolinic acid: F = 21.027, p < 0.001 [ANOVA]; BTP: F = 6.792, p < 0.01 [ANOVA]). In addition, a two-step hierarchical linear regression model showed that significant predictors of BTP levels are quinolinic acid, glomerular filtration rate and age. The neurotoxin quinolinic acid may impair blood-brain barrier integrity. BTP might be a new non-invasive biomarker to indicate quinolinic acid-induced impaired blood-brain barrier integrity. |
swb_id_str | 511124600 |
title | Beta-trace protein as a new non-invasive immunological marker for quinolinic acid-induced impaired blood-brain barrier integrity |
title_auth | Beta-trace protein as a new non-invasive immunological marker for quinolinic acid-induced impaired blood-brain barrier integrity |
title_full | Beta-trace protein as a new non-invasive immunological marker for quinolinic acid-induced impaired blood-brain barrier integrity Andreas Baranyi, Omid Amouzadeh-Ghadikolai, Dirk von Lewinski, Robert J. Breitenecker, Tatjana Stojakovic, Winfried März, Christoph Robier, Hans-Bernd Rothenhäusler, Harald Mangge & Andreas Meinitzer |
title_fullStr | Beta-trace protein as a new non-invasive immunological marker for quinolinic acid-induced impaired blood-brain barrier integrity Andreas Baranyi, Omid Amouzadeh-Ghadikolai, Dirk von Lewinski, Robert J. Breitenecker, Tatjana Stojakovic, Winfried März, Christoph Robier, Hans-Bernd Rothenhäusler, Harald Mangge & Andreas Meinitzer |
title_full_unstemmed | Beta-trace protein as a new non-invasive immunological marker for quinolinic acid-induced impaired blood-brain barrier integrity Andreas Baranyi, Omid Amouzadeh-Ghadikolai, Dirk von Lewinski, Robert J. Breitenecker, Tatjana Stojakovic, Winfried März, Christoph Robier, Hans-Bernd Rothenhäusler, Harald Mangge & Andreas Meinitzer |
title_in_hierarchy | Beta-trace protein as a new non-invasive immunological marker for quinolinic acid-induced impaired blood-brain barrier integrity / Andreas Baranyi, Omid Amouzadeh-Ghadikolai, Dirk von Lewinski, Robert J. Breitenecker, Tatjana Stojakovic, Winfried März, Christoph Robier, Hans-Bernd Rothenhäusler, Harald Mangge & Andreas Meinitzer, |
title_short | Beta-trace protein as a new non-invasive immunological marker for quinolinic acid-induced impaired blood-brain barrier integrity |
title_sort | beta trace protein as a new non invasive immunological marker for quinolinic acid induced impaired blood brain barrier integrity |
url | http://dx.doi.org/10.1038/srep43642, https://www.nature.com/articles/srep43642 |